1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Ertapenem Injection Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Ertapenem Injection by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Ertapenem Injection by Country/Region, 2017, 2022 & 2028 2.2 Ertapenem Injection Segment by Type 2.2.1 1g/Vial 2.2.2 Others 2.3 Ertapenem Injection Sales by Type 2.3.1 Global Ertapenem Injection Sales Market Share by Type (2017-2022) 2.3.2 Global Ertapenem Injection Revenue and Market Share by Type (2017-2022) 2.3.3 Global Ertapenem Injection Sale Price by Type (2017-2022) 2.4 Ertapenem Injection Segment by Application 2.4.1 Adult 2.4.2 Pediatric 2.5 Ertapenem Injection Sales by Application 2.5.1 Global Ertapenem Injection Sale Market Share by Application (2017-2022) 2.5.2 Global Ertapenem Injection Revenue and Market Share by Application (2017-2022) 2.5.3 Global Ertapenem Injection Sale Price by Application (2017-2022) 3 Global Ertapenem Injection by Company 3.1 Global Ertapenem Injection Breakdown Data by Company 3.1.1 Global Ertapenem Injection Annual Sales by Company (2020-2022) 3.1.2 Global Ertapenem Injection Sales Market Share by Company (2020-2022) 3.2 Global Ertapenem Injection Annual Revenue by Company (2020-2022) 3.2.1 Global Ertapenem Injection Revenue by Company (2020-2022) 3.2.2 Global Ertapenem Injection Revenue Market Share by Company (2020-2022) 3.3 Global Ertapenem Injection Sale Price by Company 3.4 Key Manufacturers Ertapenem Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Ertapenem Injection Product Location Distribution 3.4.2 Players Ertapenem Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Ertapenem Injection by Geographic Region 4.1 World Historic Ertapenem Injection Market Size by Geographic Region (2017-2022) 4.1.1 Global Ertapenem Injection Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Ertapenem Injection Annual Revenue by Geographic Region 4.2 World Historic Ertapenem Injection Market Size by Country/Region (2017-2022) 4.2.1 Global Ertapenem Injection Annual Sales by Country/Region (2017-2022) 4.2.2 Global Ertapenem Injection Annual Revenue by Country/Region 4.3 Americas Ertapenem Injection Sales Growth 4.4 APAC Ertapenem Injection Sales Growth 4.5 Europe Ertapenem Injection Sales Growth 4.6 Middle East & Africa Ertapenem Injection Sales Growth 5 Americas 5.1 Americas Ertapenem Injection Sales by Country 5.1.1 Americas Ertapenem Injection Sales by Country (2017-2022) 5.1.2 Americas Ertapenem Injection Revenue by Country (2017-2022) 5.2 Americas Ertapenem Injection Sales by Type 5.3 Americas Ertapenem Injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Ertapenem Injection Sales by Region 6.1.1 APAC Ertapenem Injection Sales by Region (2017-2022) 6.1.2 APAC Ertapenem Injection Revenue by Region (2017-2022) 6.2 APAC Ertapenem Injection Sales by Type 6.3 APAC Ertapenem Injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Ertapenem Injection by Country 7.1.1 Europe Ertapenem Injection Sales by Country (2017-2022) 7.1.2 Europe Ertapenem Injection Revenue by Country (2017-2022) 7.2 Europe Ertapenem Injection Sales by Type 7.3 Europe Ertapenem Injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Ertapenem Injection by Country 8.1.1 Middle East & Africa Ertapenem Injection Sales by Country (2017-2022) 8.1.2 Middle East & Africa Ertapenem Injection Revenue by Country (2017-2022) 8.2 Middle East & Africa Ertapenem Injection Sales by Type 8.3 Middle East & Africa Ertapenem Injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Ertapenem Injection 10.3 Manufacturing Process Analysis of Ertapenem Injection 10.4 Industry Chain Structure of Ertapenem Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Ertapenem Injection Distributors 11.3 Ertapenem Injection Customer 12 World Forecast Review for Ertapenem Injection by Geographic Region 12.1 Global Ertapenem Injection Market Size Forecast by Region 12.1.1 Global Ertapenem Injection Forecast by Region (2023-2028) 12.1.2 Global Ertapenem Injection Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Ertapenem Injection Forecast by Type 12.7 Global Ertapenem Injection Forecast by Application 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck Ertapenem Injection Product Offered 13.1.3 Merck Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 Endo 13.2.1 Endo Company Information 13.2.2 Endo Ertapenem Injection Product Offered 13.2.3 Endo Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Endo Main Business Overview 13.2.5 Endo Latest Developments 13.3 Aurobindo Pharma 13.3.1 Aurobindo Pharma Company Information 13.3.2 Aurobindo Pharma Ertapenem Injection Product Offered 13.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Aurobindo Pharma Main Business Overview 13.3.5 Aurobindo Pharma Latest Developments 13.4 ACS Dobfar 13.4.1 ACS Dobfar Company Information 13.4.2 ACS Dobfar Ertapenem Injection Product Offered 13.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 ACS Dobfar Main Business Overview 13.4.5 ACS Dobfar Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Ertapenem Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Ertapenem Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of 1g/Vial Table 4. Major Players of Others Table 5. Global Ertapenem Injection Sales by Type (2017-2022) & (K Units) Table 6. Global Ertapenem Injection Sales Market Share by Type (2017-2022) Table 7. Global Ertapenem Injection Revenue by Type (2017-2022) & ($ million) Table 8. Global Ertapenem Injection Revenue Market Share by Type (2017-2022) Table 9. Global Ertapenem Injection Sale Price by Type (2017-2022) & (USD/Unit) Table 10. Global Ertapenem Injection Sales by Application (2017-2022) & (K Units) Table 11. Global Ertapenem Injection Sales Market Share by Application (2017-2022) Table 12. Global Ertapenem Injection Revenue by Application (2017-2022) Table 13. Global Ertapenem Injection Revenue Market Share by Application (2017-2022) Table 14. Global Ertapenem Injection Sale Price by Application (2017-2022) & (USD/Unit) Table 15. Global Ertapenem Injection Sales by Company (2020-2022) & (K Units) Table 16. Global Ertapenem Injection Sales Market Share by Company (2020-2022) Table 17. Global Ertapenem Injection Revenue by Company (2020-2022) ($ Millions) Table 18. Global Ertapenem Injection Revenue Market Share by Company (2020-2022) Table 19. Global Ertapenem Injection Sale Price by Company (2020-2022) & (USD/Unit) Table 20. Key Manufacturers Ertapenem Injection Producing Area Distribution and Sales Area Table 21. Players Ertapenem Injection Products Offered Table 22. Ertapenem Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Ertapenem Injection Sales by Geographic Region (2017-2022) & (K Units) Table 26. Global Ertapenem Injection Sales Market Share Geographic Region (2017-2022) Table 27. Global Ertapenem Injection Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Ertapenem Injection Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Ertapenem Injection Sales by Country/Region (2017-2022) & (K Units) Table 30. Global Ertapenem Injection Sales Market Share by Country/Region (2017-2022) Table 31. Global Ertapenem Injection Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Ertapenem Injection Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Ertapenem Injection Sales by Country (2017-2022) & (K Units) Table 34. Americas Ertapenem Injection Sales Market Share by Country (2017-2022) Table 35. Americas Ertapenem Injection Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Ertapenem Injection Revenue Market Share by Country (2017-2022) Table 37. Americas Ertapenem Injection Sales by Type (2017-2022) & (K Units) Table 38. Americas Ertapenem Injection Sales Market Share by Type (2017-2022) Table 39. Americas Ertapenem Injection Sales by Application (2017-2022) & (K Units) Table 40. Americas Ertapenem Injection Sales Market Share by Application (2017-2022) Table 41. APAC Ertapenem Injection Sales by Region (2017-2022) & (K Units) Table 42. APAC Ertapenem Injection Sales Market Share by Region (2017-2022) Table 43. APAC Ertapenem Injection Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Ertapenem Injection Revenue Market Share by Region (2017-2022) Table 45. APAC Ertapenem Injection Sales by Type (2017-2022) & (K Units) Table 46. APAC Ertapenem Injection Sales Market Share by Type (2017-2022) Table 47. APAC Ertapenem Injection Sales by Application (2017-2022) & (K Units) Table 48. APAC Ertapenem Injection Sales Market Share by Application (2017-2022) Table 49. Europe Ertapenem Injection Sales by Country (2017-2022) & (K Units) Table 50. Europe Ertapenem Injection Sales Market Share by Country (2017-2022) Table 51. Europe Ertapenem Injection Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Ertapenem Injection Revenue Market Share by Country (2017-2022) Table 53. Europe Ertapenem Injection Sales by Type (2017-2022) & (K Units) Table 54. Europe Ertapenem Injection Sales Market Share by Type (2017-2022) Table 55. Europe Ertapenem Injection Sales by Application (2017-2022) & (K Units) Table 56. Europe Ertapenem Injection Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Ertapenem Injection Sales by Country (2017-2022) & (K Units) Table 58. Middle East & Africa Ertapenem Injection Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Ertapenem Injection Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Ertapenem Injection Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Ertapenem Injection Sales by Type (2017-2022) & (K Units) Table 62. Middle East & Africa Ertapenem Injection Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Ertapenem Injection Sales by Application (2017-2022) & (K Units) Table 64. Middle East & Africa Ertapenem Injection Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Ertapenem Injection Table 66. Key Market Challenges & Risks of Ertapenem Injection Table 67. Key Industry Trends of Ertapenem Injection Table 68. Ertapenem Injection Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Ertapenem Injection Distributors List Table 71. Ertapenem Injection Customer List Table 72. Global Ertapenem Injection Sales Forecast by Region (2023-2028) & (K Units) Table 73. Global Ertapenem Injection Sales Market Forecast by Region Table 74. Global Ertapenem Injection Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Ertapenem Injection Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Ertapenem Injection Sales Forecast by Country (2023-2028) & (K Units) Table 77. Americas Ertapenem Injection Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Ertapenem Injection Sales Forecast by Region (2023-2028) & (K Units) Table 79. APAC Ertapenem Injection Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Ertapenem Injection Sales Forecast by Country (2023-2028) & (K Units) Table 81. Europe Ertapenem Injection Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Ertapenem Injection Sales Forecast by Country (2023-2028) & (K Units) Table 83. Middle East & Africa Ertapenem Injection Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Ertapenem Injection Sales Forecast by Type (2023-2028) & (K Units) Table 85. Global Ertapenem Injection Sales Market Share Forecast by Type (2023-2028) Table 86. Global Ertapenem Injection Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Ertapenem Injection Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Ertapenem Injection Sales Forecast by Application (2023-2028) & (K Units) Table 89. Global Ertapenem Injection Sales Market Share Forecast by Application (2023-2028) Table 90. Global Ertapenem Injection Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Ertapenem Injection Revenue Market Share Forecast by Application (2023-2028) Table 92. Merck Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors Table 93. Merck Ertapenem Injection Product Offered Table 94. Merck Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 95. Merck Main Business Table 96. Merck Latest Developments Table 97. Endo Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors Table 98. Endo Ertapenem Injection Product Offered Table 99. Endo Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 100. Endo Main Business Table 101. Endo Latest Developments Table 102. Aurobindo Pharma Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors Table 103. Aurobindo Pharma Ertapenem Injection Product Offered Table 104. Aurobindo Pharma Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 105. Aurobindo Pharma Main Business Table 106. Aurobindo Pharma Latest Developments Table 107. ACS Dobfar Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors Table 108. ACS Dobfar Ertapenem Injection Product Offered Table 109. ACS Dobfar Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 110. ACS Dobfar Main Business Table 111. ACS Dobfar Latest Developments List of Figures Figure 1. Picture of Ertapenem Injection Figure 2. Ertapenem Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Ertapenem Injection Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Ertapenem Injection Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Ertapenem Injection Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of 1g/Vial Figure 10. Product Picture of Others Figure 11. Global Ertapenem Injection Sales Market Share by Type in 2021 Figure 12. Global Ertapenem Injection Revenue Market Share by Type (2017-2022) Figure 13. Ertapenem Injection Consumed in Adult Figure 14. Global Ertapenem Injection Market: Adult (2017-2022) & (K Units) Figure 15. Ertapenem Injection Consumed in Pediatric Figure 16. Global Ertapenem Injection Market: Pediatric (2017-2022) & (K Units) Figure 17. Global Ertapenem Injection Sales Market Share by Application (2017-2022) Figure 18. Global Ertapenem Injection Revenue Market Share by Application in 2021 Figure 19. Ertapenem Injection Revenue Market by Company in 2021 ($ Million) Figure 20. Global Ertapenem Injection Revenue Market Share by Company in 2021 Figure 21. Global Ertapenem Injection Sales Market Share by Geographic Region (2017-2022) Figure 22. Global Ertapenem Injection Revenue Market Share by Geographic Region in 2021 Figure 23. Global Ertapenem Injection Sales Market Share by Region (2017-2022) Figure 24. Global Ertapenem Injection Revenue Market Share by Country/Region in 2021 Figure 25. Americas Ertapenem Injection Sales 2017-2022 (K Units) Figure 26. Americas Ertapenem Injection Revenue 2017-2022 ($ Millions) Figure 27. APAC Ertapenem Injection Sales 2017-2022 (K Units) Figure 28. APAC Ertapenem Injection Revenue 2017-2022 ($ Millions) Figure 29. Europe Ertapenem Injection Sales 2017-2022 (K Units) Figure 30. Europe Ertapenem Injection Revenue 2017-2022 ($ Millions) Figure 31. Middle East & Africa Ertapenem Injection Sales 2017-2022 (K Units) Figure 32. Middle East & Africa Ertapenem Injection Revenue 2017-2022 ($ Millions) Figure 33. Americas Ertapenem Injection Sales Market Share by Country in 2021 Figure 34. Americas Ertapenem Injection Revenue Market Share by Country in 2021 Figure 35. United States Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 36. Canada Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 37. Mexico Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 38. Brazil Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 39. APAC Ertapenem Injection Sales Market Share by Region in 2021 Figure 40. APAC Ertapenem Injection Revenue Market Share by Regions in 2021 Figure 41. China Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 42. Japan Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 43. South Korea Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 44. Southeast Asia Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 45. India Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 46. Australia Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 47. Europe Ertapenem Injection Sales Market Share by Country in 2021 Figure 48. Europe Ertapenem Injection Revenue Market Share by Country in 2021 Figure 49. Germany Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 50. France Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 51. UK Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 52. Italy Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 53. Russia Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 54. Middle East & Africa Ertapenem Injection Sales Market Share by Country in 2021 Figure 55. Middle East & Africa Ertapenem Injection Revenue Market Share by Country in 2021 Figure 56. Egypt Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 57. South Africa Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 58. Israel Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 59. Turkey Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 60. GCC Country Ertapenem Injection Revenue Growth 2017-2022 ($ Millions) Figure 61. Manufacturing Cost Structure Analysis of Ertapenem Injection in 2021 Figure 62. Manufacturing Process Analysis of Ertapenem Injection Figure 63. Industry Chain Structure of Ertapenem Injection Figure 64. Channels of Distribution Figure 65. Distributors Profiles